Carisma Therapeutics, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
MERCK & CO., INC. | 02/14/2025 | 1.47 M | $616,993 | 100.00% | 3.55% |
BLACKROCK, INC. | 02/07/2025 | 408,147 | $170,932 | -0.10% | 0.98% |
GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 259,184 | $108,571 | 0.00% | 0.62% |
RENAISSANCE TECHNOLOGIES LLC | 02/13/2025 | 231,357 | $96,892 | 11.90% | 0.56% |
MILLENNIUM MANAGEMENT LLC | 02/14/2025 | 120,157 | $50,322 | -15.69% | 0.29% |
NORTHERN TRUST CORP | 02/14/2025 | 69,888 | $29,269 | -7.37% | 0.17% |
HRT FINANCIAL LP | 02/14/2025 | 36,902 | $15,000 | 100.00% | 0.09% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 02/14/2025 | 30,988 | $12,978 | 1.81% | 0.07% |
EMPOWERED FUNDS, LLC | 01/28/2025 | 30,988 | $12,978 | 1.81% | 0.07% |
BLODGETT WEALTH ADVISORS, LLC | 01/24/2025 | 24,001 | $10,052 | -4.00% | 0.06% |
VIRTU FINANCIAL LLC | 02/11/2025 | 17,327 | $7,000 | 100.00% | 0.04% |
STRATOS WEALTH PARTNERS, LTD. | 01/27/2025 | 12,200 | $5,109 | 0.00% | 0.03% |
BAADER BANK AKTIENGESELLSCHAFT | 01/23/2025 | 11,804 | $4,425 | 100.00% | 0.03% |
TWO SIGMA SECURITIES, LLC | 02/14/2025 | 11,432 | $4,788 | 100.00% | 0.03% |
TOWER RESEARCH CAPITAL LLC (TRC) | 02/13/2025 | 7,827 | $3,280 | 73.01% | 0.02% |
BANK OF AMERICA CORP /DE/ | 02/14/2025 | 7,277 | $3,042 | -0.05% | 0.02% |
MORGAN STANLEY | 02/14/2025 | 5,685 | $2,381 | 0.00% | 0.01% |
FEDERATED HERMES, INC. | 02/13/2025 | 4,973 | $2,083 | 0.00% | 0.01% |
GROUP ONE TRADING, L.P. | 02/14/2025 | 2,230 | $934 | 0.00% | 0.01% |
02/04/2025 | 535 | $227 | 100.00% | 0.00% | |
BANK & TRUST CO | 01/07/2025 | 525 | $220 | 0.00% | 0.00% |
PEOPLES BANK/KS | 01/08/2025 | 250 | $102 | 0.00% | 0.00% |
ORG PARTNERS LLC | 01/10/2025 | 200 | $83 | 0.00% | 0.00% |
CAROLINA WEALTH ADVISORS, LLC | 01/14/2025 | 150 | $63 | 100.00% | 0.00% |
NATIONAL BANK OF CANADA /FI/ | 02/12/2025 | 50 | $21 | -69.70% | 0.00% |
HARBOUR INVESTMENTS, INC. | 02/10/2025 | 37 | $15 | 0.00% | 0.00% |
02/06/2025 | 31 | $13 | 100.00% | 0.00% | |
CITIGROUP INC | 02/12/2025 | 10 | $4 | 0.00% | 0.00% |
FMR LLC | 02/13/2025 | 0 | $0 | -100.00% | 0.00% |
NISA INVESTMENT ADVISORS, LLC | 01/17/2025 | 0 | $0 | -100.00% | 0.00% |
WEXFORD CAPITAL LP | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
TWO SIGMA INVESTMENTS, LP | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
MFA WEALTH ADVISORS, LLC | 01/29/2025 | 0 | $0 | -100.00% | 0.00% |
QUBE RESEARCH & TECHNOLOGIES LTD | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
02/10/2025 | 0 | $0 | -100.00% | 0.00% | |
TPG GP A, LLC | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
CAPITAL PERFORMANCE ADVISORS LLP | 01/31/2025 | 0 | $0 | -100.00% | 0.00% |
Carisma Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 35 institutional investors and hedge funds held shares of Carisma Therapeutics, Inc.. The most heavily invested institutionals were:
Merck & Co., Inc.: 1.47 M
BlackRock, Inc.: 408,147
GEODE CAPITAL MANAGEMENT, LLC: 259,184
RENAISSANCE TECHNOLOGIES LLC: 231,357
MILLENNIUM MANAGEMENT LLC: 120,157
NORTHERN TRUST CORP: 69,888
11.51% of Carisma Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 4.77 M shares in the last 24 months. This purchase volume represents approximately $906,041 in transactions.